Ownership history in MORGAN STANLEY · 10 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in ACURX PHARMACEUTICALS INC (ACXP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 6,500 | +1,190 | +22.4% | 0.00% | $16K | $2.49 |
| 2025 Q3 | REDUCED | 5,310 | -100,891 | -95.0% | 0.00% | $23K | $4.29 |
| 2025 Q2 | UNCHANGED | 106,201 | — | 0% | 0.00% | $54K | $10.22 |
| 2025 Q1 | UNCHANGED | 106,201 | — | 0% | 0.00% | $41K | $7.80 |
| 2024 Q4 | ADDED | 106,201 | +60,000 | +129.9% | 0.00% | $86K | $16.28 |
| 2024 Q3 | REDUCED | 46,201 | -200 | -0.4% | 0.00% | $88K | $38.00 |
| 2024 Q2 | ADDED | 46,401 | +20,000 | +75.8% | 0.00% | $104K | $45.00 |
| 2024 Q1 | ADDED | 26,401 | +10,200 | +63.0% | 0.00% | $65K | $49.00 |
| 2023 Q4 | ADDED | 16,201 | +1,201 | +8.0% | 0.00% | $62K | $76.60 |
| 2023 Q3 | INITIATED | 15,000 | — | — | 0.00% | $22K | — |
As of 2025 Q4 — sorted by position size